Diseases, Conditions, Syndromes

New advances in the management of patients with cirrhosis

New data from clinical studies presented for the first time at the International Liver Congress 2013 provide new rationale for an old and established treatment option for portal hypertension. Additionally, spleen stiffness ...

Diseases, Conditions, Syndromes

New focus for chronic liver disease care

Developing improved care models for decompensated liver disease is one of the major clinical challenges in gastroenterology and hepatology, and in a recent landmark study, published in Hepatology, researches from Flinders ...

Diseases, Conditions, Syndromes

Telaprevir: Added benefit in certain patients with hepatitis C

The drug telaprevir (trade name: Incivo) has been available for treatment of chronic hepatitis C infection of genotype 1 since autumn 2011. In an early benefit assessment pursuant to the "Act on the Reform of the Market for ...

Diseases, Conditions, Syndromes

HBcrAg levels tied to progression to cirrhosis in HBV carriers

(HealthDay)—For hepatitis B virus (HBV) carriers, hepatitis B virus core-related antigen (HBcrAg) levels are associated with progression to cirrhosis, according to a study published online Sept. 15 in the Journal of Gastroenterology ...

Obstetrics & gynaecology

Many infants with hep C-positive moms not screened for HCV

(HealthDay)—Less than one-third of infants born to mothers with hepatitis C virus infection (HCV+) receive appropriate HCV follow-up testing, according to a study presented at The Liver Meeting, the annual meeting of the ...

Diseases, Conditions, Syndromes

Blood tests as good as biopsy for HCV-related disease

(HealthDay)—Compared to a liver biopsy, available blood tests are accurate for diagnosing fibrosis and cirrhosis in patients with hepatitis C virus (HCV), according to a review published in the June 4 issue of the Annals ...

Diseases, Conditions, Syndromes

Peru: Liver cancer like no other

Liver cancer is the sixth most common cancer worldwide and the third most deadly. It mainly affects men over the age of 40, most often with cirrhosis or hepatitis B or C. But in Peru, it also uncharacteristically affects ...

page 13 from 17